{"nct_id":"NCT01209286","title":"Study of the BiTE® Blinatumomab (MT103) in Adult Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL)","status":"COMPLETED","status_verified_date":"2016-07","start_date":"2010-10","start_date_type":null,"primary_completion_date":"2012-03","primary_completion_date_type":"ACTUAL","completion_date":"2016-10","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AMGN"]}